Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a completed phase 3 study of pembrolizumab-based treatments and the EXTREME regimen for recurrent or metastatic head and neck cancer, including its eligibility criteria, treatment arms, outcomes, and locations.
    Difference
    86%
    Check dated 2026-11-10T06:42:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer's site revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T02:16:27.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-27T02:24:39.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer revision advances from v3.7.1 to v3.7.2 while the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-20T04:49:08.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T07:34:43.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Users attempting to view the study record now encounter a 403 Forbidden page, blocking access to the study details and related information.
    Difference
    18%
    Check dated 2026-09-22T02:36:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.